287 related articles for article (PubMed ID: 18761748)
1. Elevated autoantibody content in rheumatoid arthritis synovia with lymphoid aggregates and the effect of rituximab.
Rosengren S; Wei N; Kalunian KC; Zvaifler NJ; Kavanaugh A; Boyle DL
Arthritis Res Ther; 2008; 10(5):R105. PubMed ID: 18761748
[TBL] [Abstract][Full Text] [Related]
2. Antibodies to Cyclic Citrullinated Peptides in Patients With Juvenile Idiopathic Arthritis and Patients With Rheumatoid Arthritis: Shared Expression of the Inherently Autoreactive 9G4 Idiotype.
Peckham H; Cambridge G; Bourke L; Sen D; Radziszewska A; Leandro M; Ioannou Y
Arthritis Rheumatol; 2017 Jul; 69(7):1387-1395. PubMed ID: 28380667
[TBL] [Abstract][Full Text] [Related]
3. Inflammation and autoantibody markers identify rheumatoid arthritis patients with enhanced clinical benefit following rituximab treatment.
Lal P; Su Z; Holweg CT; Silverman GJ; Schwartzman S; Kelman A; Read S; Spaniolo G; Monroe JG; Behrens TW; Townsend MJ
Arthritis Rheum; 2011 Dec; 63(12):3681-91. PubMed ID: 22127691
[TBL] [Abstract][Full Text] [Related]
4. Elevated serum and synovial fluid TNF-like ligand 1A (TL1A) is associated with autoantibody production in patients with rheumatoid arthritis.
Sun X; Zhao J; Liu R; Jia R; Sun L; Li X; Li Z
Scand J Rheumatol; 2013; 42(2):97-101. PubMed ID: 23311967
[TBL] [Abstract][Full Text] [Related]
5. Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis.
Caspi D; Anouk M; Golan I; Paran D; Kaufman I; Wigler I; Levartovsky D; Litinsky I; Elkayam O
Arthritis Rheum; 2006 Feb; 55(1):53-6. PubMed ID: 16463412
[TBL] [Abstract][Full Text] [Related]
6. Prospective cohort study of effects of infliximab on rheumatoid factor, anti-cyclic citrullinated peptide antibodies and antinuclear antibodies in patients with long-standing rheumatoid arthritis.
Bruns A; Nicaise-Roland P; Hayem G; Palazzo E; Dieudé P; Grootenboer-Mignot S; Chollet-Martin S; Meyer O
Joint Bone Spine; 2009 May; 76(3):248-53. PubMed ID: 19208451
[TBL] [Abstract][Full Text] [Related]
7. Rheumatoid factor, but not anti-cyclic citrullinated peptide antibodies, is modulated by infliximab treatment in rheumatoid arthritis.
De Rycke L; Verhelst X; Kruithof E; Van den Bosch F; Hoffman IE; Veys EM; De Keyser F
Ann Rheum Dis; 2005 Feb; 64(2):299-302. PubMed ID: 15166003
[TBL] [Abstract][Full Text] [Related]
8. Synovial tissue response to rituximab: mechanism of action and identification of biomarkers of response.
Thurlings RM; Vos K; Wijbrandts CA; Zwinderman AH; Gerlag DM; Tak PP
Ann Rheum Dis; 2008 Jul; 67(7):917-25. PubMed ID: 17965121
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical analysis as a means to predict responsiveness to rituximab treatment.
Teng YK; Levarht EW; Hashemi M; Bajema IM; Toes RE; Huizinga TW; van Laar JM
Arthritis Rheum; 2007 Dec; 56(12):3909-18. PubMed ID: 18050222
[TBL] [Abstract][Full Text] [Related]
10. Anti-cyclic citrullinated peptide antibody isotypes in rheumatoid arthritis: association with disease duration, rheumatoid factor production and the presence of shared epitope.
Lakos G; Soós L; Fekete A; Szabó Z; Zeher M; Horváth IF; Dankó K; Kapitány A; Gyetvai A; Szegedi G; Szekanecz Z
Clin Exp Rheumatol; 2008; 26(2):253-60. PubMed ID: 18565246
[TBL] [Abstract][Full Text] [Related]
11. Impact of treatment with infliximab on anticyclic citrullinated peptide antibody and rheumatoid factor in patients with rheumatoid arthritis.
Ahmed MM; Mubashir E; Wolf RE; Hayat S; Hall V; Shi R; Berney SM
South Med J; 2006 Nov; 99(11):1209-15. PubMed ID: 17195414
[TBL] [Abstract][Full Text] [Related]
12. Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis.
Greiner A; Plischke H; Kellner H; Gruber R
Ann N Y Acad Sci; 2005 Jun; 1050():295-303. PubMed ID: 16014545
[TBL] [Abstract][Full Text] [Related]
13. Antibodies of IgG, IgA and IgM isotypes against cyclic citrullinated peptide precede the development of rheumatoid arthritis.
Kokkonen H; Mullazehi M; Berglin E; Hallmans G; Wadell G; Rönnelid J; Rantapää-Dahlqvist S
Arthritis Res Ther; 2011 Feb; 13(1):R13. PubMed ID: 21291540
[TBL] [Abstract][Full Text] [Related]
14. Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis.
Cambridge G; Leandro MJ; Edwards JC; Ehrenstein MR; Salden M; Bodman-Smith M; Webster AD
Arthritis Rheum; 2003 Aug; 48(8):2146-54. PubMed ID: 12905467
[TBL] [Abstract][Full Text] [Related]
15. IL-40: A New B Cell-Associated Cytokine Up-Regulated in Rheumatoid Arthritis Decreases Following the Rituximab Therapy and Correlates With Disease Activity, Autoantibodies, and NETosis.
Navrátilová A; Andrés Cerezo L; Hulejová H; Bečvář V; Tomčík M; Komarc M; Veigl D; Tegzová D; Závada J; Olejárová M; Pavelka K; Vencovský J; Šenolt L
Front Immunol; 2021; 12():745523. PubMed ID: 34745117
[TBL] [Abstract][Full Text] [Related]
16. B cell activation biomarkers as predictive factors for the response to rituximab in rheumatoid arthritis: a six-month, national, multicenter, open-label study.
Sellam J; Hendel-Chavez H; Rouanet S; Abbed K; Combe B; Le Loët X; Tebib J; Sibilia J; Taoufik Y; Dougados M; Mariette X
Arthritis Rheum; 2011 Apr; 63(4):933-8. PubMed ID: 21225699
[TBL] [Abstract][Full Text] [Related]
17. Ethnic differences in the prognostic utility of rheumatoid factor isotypes and anticyclic citrullinated peptides in rheumatoid arthritis patients: a cross-sectional study.
Gomez EL; Gun SC; Somanath SD; Chinna K; Radhakrishnan AK
Mod Rheumatol; 2013 Jul; 23(4):716-21. PubMed ID: 22854883
[TBL] [Abstract][Full Text] [Related]
18. Anti-cyclic citrullinated peptide antibody determination in synovial fluid of psoriatic arthritis.
Spadaro A; Riccieri V; Scrivo R; Alessandri C; Valesini G
Clin Exp Rheumatol; 2007; 25(4):599-604. PubMed ID: 17888217
[TBL] [Abstract][Full Text] [Related]
19. Autoantibodies in rheumatoid arthritis: association with severity of disease in established RA.
Agrawal S; Misra R; Aggarwal A
Clin Rheumatol; 2007 Feb; 26(2):201-4. PubMed ID: 16572283
[TBL] [Abstract][Full Text] [Related]
20. Anti-agalactosyl IgG antibodies in Thai patients with rheumatoid arthritis, systemic lupus erythematosus, and systemic sclerosis.
Louthrenoo W; Kasitanon N; Wichainun R; Wangkaew S; Sukitawut W; Kuwata S; Takeuchi F
Clin Rheumatol; 2010 Mar; 29(3):241-6. PubMed ID: 20091076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
